These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 6273645

  • 1. Natriuretic hormone - a circulating inhibitor of sodium- and potassium-activated adenosine triphosphatase. Its potential role in body fluid and blood pressure regulation.
    Kramer HJ.
    Klin Wochenschr; 1981 Nov 16; 59(22):1225-30. PubMed ID: 6273645
    [Abstract] [Full Text] [Related]

  • 2. The role of endogenous inhibition of Na-K-ATPase in human hypertension--sodium pump activity as a determinant of peripheral vascular resistance.
    Kramer HJ, Glänzer K, Sorger M.
    Clin Exp Hypertens A; 1985 Nov 16; 7(5-6):769-82. PubMed ID: 2990771
    [Abstract] [Full Text] [Related]

  • 3. Studies on the role of sodium- and potassium-activated adenosine triphosphatase inhibition in the pathogenesis of human hypertension. Changes in vascular and cardiac function following inhibition of the sodium pump in normotensive subjects and effects of calcium entry blockade.
    Kramer HJ, Glänzer K, Freitag T, Schönfeld J, Sorger M, Schlebusch H, Düsing R, Krück F.
    Klin Wochenschr; 1985 Jan 02; 63(1):32-6. PubMed ID: 2579261
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Digitalislike circulating factor in hypertension: potential messenger between salt balance and intracellular sodium.
    Haddy FJ.
    Cardiovasc Drugs Ther; 1990 Mar 02; 4 Suppl 2():343-9. PubMed ID: 2176807
    [Abstract] [Full Text] [Related]

  • 6. [Endogenous natriuretic and ouabain-like factors. Their potential role in volume and blood pressure regulation].
    Kramer HJ, Bäcker A, Krampitz G, Meyer-Lehnert H, Michel H.
    Klin Wochenschr; 1990 Nov 16; 68(22):1112-8. PubMed ID: 2177810
    [Abstract] [Full Text] [Related]

  • 7. Studies on ouabain-like endogenous natriuretic factors in human urine. Inhibition of Na-K-ATPase and 3H-ouabain binding.
    Kramer HJ, Baecker A, Weiler E, Liddiard C.
    Klin Wochenschr; 1986 Aug 15; 64(16):760-6. PubMed ID: 3020314
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Sodium transport inhibition, cell calcium, and hypertension. The natriuretic hormone/Na+-Ca2+ exchange/hypertension hypothesis.
    Blaustein MP, Hamlyn JM.
    Am J Med; 1984 Oct 05; 77(4A):45-59. PubMed ID: 6091450
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Volume hormones and blood pressure.
    Genest J.
    Ann Intern Med; 1983 May 05; 98(5 Pt 2):744-9. PubMed ID: 6303174
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Circulating inhibitor of sodium-potassium-activated adenosine triphosphatase after expansion of extracellular fluid volume in rats.
    Gonick HC, Kramer HJ, Paul W, Lu E.
    Clin Sci Mol Med; 1977 Oct 05; 53(4):329-34. PubMed ID: 144041
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.